Novo Nordisk A/S
NONOFOTCHealthcare● Active
$41.25
$-2.11(-4.87%)
Market Cap$183.3B
P/E Ratio—
52W High$82.5
52W Low$34
Novo Nordisk A/S (NONOF) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NONOF · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $26.90B | $26.31B | $30.23B | $23.57B | $17.48B |
| Net Receivables | $75.53B | $87.41B | $75.26B | $57.51B | $46.80B |
| Inventory | $49.51B | $40.85B | $31.81B | $24.39B | $19.62B |
| Total Current Assets | $172.06B | $160.90B | $139.65B | $108.19B | $85.59B |
| PP&E Net | $207.91B | $162.49B | $90.96B | $66.67B | $55.36B |
| Goodwill | $19.80B | $20.06B | $4.46B | $4.62B | $4.35B |
| Intangible Assets | $109.96B | $91.03B | $55.94B | $46.32B | $38.83B |
| Total Assets | $541.67B | $465.80B | $314.49B | $241.26B | $194.51B |
| Liabilities | |||||
| Short-Term Debt | $10.68B | $11.78B | $5.30B | $0.48B | $12.86B |
| Accounts Payable | $19.71B | $28.85B | $25.61B | $15.59B | $8.87B |
| Total Current Liabilities | $215.17B | $217.53B | $169.66B | $120.94B | $99.52B |
| Long-Term Debt | $118.67B | $84.25B | $15.98B | $20.77B | $9.65B |
| Total Liabilities | $348.06B | $322.31B | $207.93B | $157.77B | $123.76B |
| Stockholders Equity | |||||
| Retained Earnings | $194.86B | $144.45B | $104.84B | $80.59B | $72.00B |
| Total Stockholders Equity | $193.61B | $143.49B | $106.56B | $83.49B | $70.75B |
| Total Liab & Equity(computed) | $541.67B | $465.80B | $314.49B | $241.26B | $194.51B |
| Debt Summary | |||||
| Total Debt | $137.88B | $102.79B | $27.01B | $25.78B | $26.64B |
| Net Debt | $111.48B | $87.13B | $12.61B | $13.13B | $15.93B |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · DKK · B
Explore more Novo Nordisk A/S data
About Novo Nordisk A/S (NONOF) Balance Sheet
Novo Nordisk A/S (NONOF) balance sheet shows total assets of $541.67B with cash of $26.90B. Total liabilities are $348.06B, total debt $137.88B, and stockholders equity $193.61B.
Frequently asked questions
NONOF · 4 questionsNovo Nordisk A/S has total debt of $137.88B with net debt of $111.48B.
NONOF total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10